Background {#Sec1}
==========

About 400,000 surgical site infections (SSIs) are documented annually in the United States, with associated costs of around \$21,000 per case \[[@CR1], [@CR2]\]. Prevalent organisms associated with SSIs, such as *Staphylococcus aureus*, *Enterococcus* species, *Klebsiella spp.*, *Pseudomonas aeruginosa,* and *Escherichia coli,* can persist on surfaces from 1.5 h to more than 30 months \[[@CR3]\].

Standard manual cleaning alone is not sufficient to eliminate these pathogens; only around 47% of surfaces are appropriately disinfected during between-case and end-of-day terminal manual cleaning \[[@CR4]\]. Implementation of efficient environmental disinfection methods as a supplement to manual cleaning may aid in reducing the risk of wound contamination and subsequent infection, thus eliminating the possible transmission of pathogens to patients \[[@CR5], [@CR6]\].

The portable ultraviolet light germicidal device employing pulsed xenon lamps (PX-UV) has been shown to be a safe, easy-to-operate, and effective system in decreasing the number of pathogens \[[@CR7]\]. PX-UV uses a xenon flash lamp to generate broad-spectrum, high-intensity ultraviolet light to deactivate and kill bacteria, spores, and viruses on high-touch surfaces in 5 min or less \[[@CR7]\]. Two studies have shown that the use of PX-UV in addition to standard end-of-day manual cleaning helped reduce bacterial contamination levels on surfaces in the operating rooms (ORs) by 62% and 81% \[[@CR8], [@CR9]\].

Furthermore, it was shown that contamination in the OR increases with sequential cases, leading to a more contaminated environment for each subsequent patient during operative hours \[[@CR9]\]. Hence, rapid and effective between-case cleaning could reduce environmental contamination, protecting subsequent patients during the same day of operation. While improved patient outcomes have been observed after PX-UV during nightly terminal cleaning practices \[[@CR8], [@CR9]\], no data are available on the impact of this technology when applied between surgical cases.

In this study, we aimed to determine the sufficient time required by the PX-UV device to reach environmental cleanliness.

Methods {#Sec2}
=======

This environmental sampling study was conducted at The University of Texas MD Anderson Cancer Center. The sampling occurred between the last end-of-case cleaning and the nightly standard terminal cleaning practices. Cleaning efficacy was assessed after 1, 2, and 8 min of PX-UV cycles using a PX-UV device (Xenex Disinfection Services). These cycle times were chosen based on proof-of-concept experiments conducted in the laboratory setting (data not shown). For each OR, high-touch surfaces were sampled at two distinct time points: after standard end-of-case cleaning and after PX-UV disinfection.

At the conclusion of surgical cases each day, the room was cleaned by OR staff according to standard end-of-case protocols (manual cleaning with ready-to-use germicidal wipes or diluted solution). Following this cleaning by not more than 1.5 h, samples from 5 high-touch surfaces (computer monitor, electrocautery unit, anesthesia cart, chair, and bed table controls) were collected for quantitative culturing using Tryptic Soy Agar contact plates. For non-flat surfaces, the plates were rolled so that their entire area came in contact with the high-touch surface. The ORs were then disinfected with a PX-UV device for 1, 2, or 8 min (10 rooms for each cycle time) at the head of the table, ensuring direct line of sight for the UV light for high-touch surfaces (Fig. [1](#Fig1){ref-type="fig"}). Following PX-UV disinfection, the same 5 high-touch surfaces were sampled at sites adjacent to the first sites using Tryptic Soy Agar contact plates. After 48-h incubation at 37 °C of the plates, colony counts were recorded. We sampled 30 ORs, generating 150 samples before PX-UV use and 150 samples after PX-UV. Table [1](#Tab1){ref-type="table"} gives a detailed description of all cases in each sampled OR (Table [1](#Tab1){ref-type="table"}).Fig. 1Schematic design of an operating room showing the accurate position of the PX-UV device (purple) to ensure direct line of sight of the UV light to the high-touch surfaces (identified as **a** to **h**) Table 1Description of the case flow and case types of the 30 sampled operating roomsORPX-UV cycle time (minutes)Mean c.f.u. before PX-UVMean c.f.u. after PX-UVTotal number of cases during the dayConsecutive case typeLast case type of the day before PX-UV110.60.83Laparotomy; Incision and Drainage; MastectomyMastectomy214.21.4 ↓2Wide Local Excision; Neck DissectionNeck Dissection311.21.63Laparoscopic Nephrectomy; Laparoscopic AdrenalectomyPartial Nephrectomy412.31.4 ↓3Mastectomy, Wide Local ExcisionExcision of lesion on back513.21.4 ↓1Laminectomy with stabilizationLaminectomy with stabilization612.80.4 ↓2NephrectomyDiagnostic Laparostomy716.22.2 ↓2Thyroid with Neck DissectionClosure of enterostomy812.22.62ParotidectomyExamination under Anaesthesia with biopsies914.23.6 ↓1Removal of tibial nail hardware and complex closureRemoval of tibial nail hardware & complex closure1011.01.63Insertion of Port-A-CathInsertion of Port-A-Cath1120.00.0 ↓1Partial Excision of genitalia with reconstructionPartial Excision of genitalia with reconstruction1221.01.22closure of enterostomyPartial colectomy1321.82.21Laparoscopic GastrectomyLaparoscopic Gastrectomy1421.40.6 ↓2Tandem and Ovoid insertionTandem and Ovoid insertion1521.00.6 ↓1Partial Lobectomy Liver and HysterectomyPartial Lobectomy Liver and Hysterectomy1621.40.8 ↓2Diagnostic Lap with Central Venous Catheter insertionDiagnostic Laparotomy with CVC insertion1722.20.4 ↓2Experimental Laparoscopy with bowel anastomosisExcision of groin lymph node1822.61.6 ↓1Proctectomy, Hysterectomy and reconstructionProctectomy, Hysterectomy and reconstruction19211.80.8 ↓2Lap HysterectomyLap Hysterectomy2021.40.4 ↓3Insertion of central lineThoracoscopy with segmental lung resection2181.20.6 ↓1CraniotomyCraniotomy2283.21.0 ↓2Laparoscopic liver resectionClosure of enterostomy and Laparoscopic liver2383.20.8 ↓2Port-A-Cath insertionDiagnostic Laparotomy with liver biopsies2484.00.6 ↓2Mastectomy with reconstructionSegmental Mastectomy25810.81.6 ↓1Mastectomy with reconstructionMastectomy with reconstruction2681.40.0 ↓3Diagnostic Laparostomy with Hysterectomy; Incision and Drainage cystCystoscopy with biopsies2780.80.2 ↓2Laparoscopic Salpingo-OophorectomyDiagnostic Laparotomy with biopsies2882.20.6 ↓2ThyroidectomyMastectomy2987.82.6 ↓1Partial colectomy with nephrectomyPartial colectomy with nephrectomy3087.60.5 ↓1Thoracotomy with Lobectomy and Pulmonary Arterial reconstructionThoracotomy with Lobectomy and Pulmonary Arterial reconstruction*Abbreviations: OR, Operating Room; PX-UV, pulsed xenon ultraviolet; c.f.u., Colony-forming units. The symbol "*↓" *indicates a decrease in c.f.u. after PX-UV*

The pre-PX-UV samples were combined for analysis to remove any variance issue. Means, medians, and ranges of colony counts were recorded at each sampling period for statistical analysis. As the data were nonparametric, a Wilcoxon rank sum test was used to examine the differences between groups.

Results {#Sec3}
=======

A total of 147 pre-PX-UV samples and 148 post-PX-UV samples measuring bacterial load obtained for the 5 high-touch surfaces were included in the analysis. Five plates (3 in the pre-PX-UV group and 2 in post-PX-UV groups) were discarded from the analysis as outliers because of counts that were too numerous to count (TNTC) and attributed to lab error, such as a dislodged cover plate. If included in the analysis, the outliers would have had undue leverage on the data for the intervention group that had no outliers (the 1-min group), and therefore the removal of the outliers was deemed conservative.

Table [2](#Tab2){ref-type="table"} depicts the changes in the colony-forming units (c.f.u.) between pre- and post-PX-UV use at different cycle times. A 1-min cycle of PX-UV did not generate a significant reduction in the level of contamination on the high-touch surfaces (*P* = 0.594). However, 2- and 8-min cycles showed significant reduction in the level of environmental contamination by decreasing the mean colony counts by 72.5% (*P* = 0.0328) and 73.1% (*P* = 0.0075), respectively (Table [2](#Tab2){ref-type="table"}). A 2-min PX-UV cycle was as effective in eliminating an equal load of bacterial contamination when compared to an 8-min cycle.Table 2Efficacy of 1-, 2-, and 8-min PX-UV disinfection cycle times in reducing operating room contaminationTiming of samplingSamples taken (*n*)Colony count (c.f.u.)Reduction^a^ (%)*P*-valueMeanMinMaxIQRPre PX-UV (all cycles combined)1473.190553----Post 1-min PX-UV501.70014246.70.5940Post 2-min PX-UV490.8809172.50.0328Post 8-min PX-UV490.8607173.10.0075^a^Reduction of mean colony count after PX-UV in comparison with pre-PX-UV mean colony count. PX-UV, pulsed xenon ultraviolet; IQR, Interquartile range; c.f.u., Colony-forming units; min, minimum; max, maximum

Discussion {#Sec4}
==========

We found PX-UV disinfection effective in reducing colony counts when performed after standard cleaning. The 2- and 8-min PX-UV cycles produced equivalent and significant reduction of level of contamination when compared to standard OR cleaning alone and were more effective than the 1-min PX-UV cycle. We conclude that a 2-min cycle optimizes efficacy and efficiency.

A recent meta-analysis of financial impact on the United States healthcare system showed that SSIs contribute to 33.7% of the overall annual cost (\$9.8 billion) of healthcare-associated infections \[[@CR2]\]. By implementing this SSI prevention approach in the OR setting, contamination in the OR could be controlled during sequential cases, leading to a decontaminated environment for subsequent patients and may have positive impact on the rate of SSIs and associated costs.

PX-UV has been successfully used to reduce or eliminate pathogens such as vancomycin-resistant enterococci, Methicillin-resistant *Staphylococcus aureus* (MRSA), as well as *Clostridium difficile* on high-touch surfaces in patient rooms \[[@CR10], [@CR11]\]. In fact, PX-UV combined with quaternary ammonium removed 95% of *C. difficile* spores compared to a 70% of spores reduction when disinfecting patient rooms with bleach \[[@CR10]\]. Moreover, PX-UV was 16 times more effective than manual cleaning in eliminating MRSA \[[@CR12]\] and 100% effective against VRE \[[@CR11]\]. The efficacy of this method has also been confirmed against fungi, *Bacillus anthracis*, and viruses such as Ebola virus \[[@CR13]\]. In addition, PX-UV does not damage materials in hospital settings and is not transmitted through glass windows \[[@CR10]\].

Another method for decontaminating OR rooms between cases is the use of improved hydrogen peroxide products (IHP) such as Activated Hydrogen Peroxide (Clorox Healthcare). Even though this disinfectant is effective in reducing the contamination level to around 84% of the baseline, it presents a major limitation, i.e., manual cleaning for about 2 to 4.5 h \[[@CR14]\]. Manual cleaning is not predictable nor optimal being dependent upon the education of the cleaning personnel and the nurses \[[@CR15], [@CR16]\]. In fact, when cleaning, tools such as buckets, mop heads, and wipes can rapidly become contaminated and potentially transfer pathogens to other cleaned surfaces \[[@CR7]\]. Also, the continual and recurrent use of the same chemical disinfectant can lead to the emergence of resistant microorganisms \[[@CR7]\]. Moreover, the time spent on manually cleaning constitutes an important drawback in ORs where rapid bed turnaround time is crucial and entails operational costs for training specialized personnel. Finally, IHP costs around \$175 per room, whereas the PX-UV device costs approximately \$3 per room to operate, excluding labor costs in both cases \[[@CR10]\].

The present study was limited to 5 high-touch surfaces. Other high-touch surfaces such as floors, light switches, cabinet handles, and doorknobs could be added to future studies. Additional limitations are the somewhat small sample size used in this study and the lack of bacterial identification to the species level by our use of TSA sampling plates, which are limited in detection to aerobic bacteria only. Moreover, the impact of PX-UV use between cases on SSIs and identification of bacteria at the species level on ORs surfaces still need to be determined in future studies. Finally, an operational study that investigate the impact of the between-case use of PX-UV on OR case flow would be necessary.

Conclusions {#Sec5}
===========

In summary, our results suggest that supplementing standard cleaning procedures using a portable no-touch PX-UV system could be done routinely and rapidly between cases in the OR. A cycle of 2 min was sufficient in eliminating 70% or more of the bacterial load on inanimate high-touch surfaces, thus allowing short time for room turnover and potentially reducing pathogen transmission to patients and possibly SSI rates.
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